Search Resources (English): Women and Health Protection (WHP)

Ann Rochon Ford, coordinator of Women and Health Protection composed a letter of concerns around the process of Health Canada's regulation hearings for breast implant use in Canada.  The link includes the reply from Health Canada and further concerns raised by Rochon Ford.

This letter raises concerns about the risks to public health of an advertisement for a prescription drug, Celebrex (celecoxib), that aired on Canadian television. The letter asks Minister Tony Clement to take immediate regulatory action to stop this advertising campaign and to impose sanctions on the sponsor, Pfizer, to prevent future violations.

This letter to Health Canada argues that the pharmaceutical manufacturer, Pfizer, has been running television ads with misleading information on cardiovascular risks and using Canadian's fear of death from heart disease in order to promote sales of its product.  It urges Health Canada to take regulatory action on this campaign.